UK markets closed

RegeneRx Biopharmaceuticals, Inc. (RGRX)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.00140.0000 (0.00%)
As of 01:15PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2022
31/12/2021
31/12/2020
Total revenue
76.76
76.761
76.761
76.761
Operating expenses
Research development
-
0
6.638
4.921
Selling general and administrative
1,440
1,479
1,399
1,366
Total operating expenses
1,440
1,479
1,405
1,371
Operating income or loss
-1,363
-1,402
-1,329
-1,295
Interest expense
325.647
325.647
324.878
232.631
Total other income/expenses net
-
-
55.4
-
Income before tax
-1,689
-1,727
-1,598
-1,523
Income tax expense
0
0
0
0
Income from continuing operations
-1,689
-1,727
-1,598
-1,523
Net income
-1,689
-1,727
-1,598
-1,523
Net income available to common shareholders
-1,689
-1,727
-1,598
-1,523
Basic EPS
-0.97
-1.00
-1.00
-1.00
Diluted EPS
-0.97
-1.00
-1.00
-1.00
Basic average shares
1,435
1,435
1,386
1,334
Diluted average shares
1,435
1,435
1,386
1,334